Literature DB >> 7487494

Induction of protective antibody responses against pseudorabies virus by intranasal vaccination with glycoprotein B in mice.

A Takada1, H Kida.   

Abstract

Intranasal vaccination of mice with glycoprotein B (gB) of pseudorabies virus (PRV) induced specific IgA and IgG antibody responses in the secretion of the respiratory tract, resulting in protection of the animals against intranasal challenge with a lethal dose of virulent PRV. The immune response was enhanced by the use of cholera toxin B subunit as an adjuvant. The present results indicate that local vaccination with gB is a promising strategy to confer protective immunity on animals against PRV infection by inducing secretory antibodies on their mucosal surfaces where the primary replication of the virus occurs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487494     DOI: 10.1007/bf01322536

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus.

Authors:  H Kida; L E Brown; R G Webster
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

3.  Vaccination of cattle against pseudorabies (Aujeszky's disease) with homologous virus (herpes suis) and heterologous virus (herpes bovis 1).

Authors:  P Biront; J Vandeputte; M B Pensaert; J Leunen
Journal:  Am J Vet Res       Date:  1982-05       Impact factor: 1.156

4.  Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.

Authors:  S J McKenzie; J F Halsey
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.

Authors:  X P Liang; M E Lamm; J G Nedrud
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

6.  Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1.

Authors:  I Rauh; F Weiland; F Fehler; G M Keil; T C Mettenleiter
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Constitutively expressing cell lines that secrete a truncated bovine herpes virus-1 glycoprotein (gpI) stimulate T-lymphocyte responsiveness.

Authors:  T P Leary; Y Gao; G A Splitter
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

8.  Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.

Authors:  I Rauh; T C Mettenleiter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

Authors:  W S Gallichan; D C Johnson; F L Graham; K L Rosenthal
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

10.  Differentiation of vaccine strains and field isolates of pseudorabies (Aujeszky's disease) virus: trypsin sensitivity and mouse virulence markers.

Authors:  K B Platt; C J Maré; P N Hinz
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

View more
  2 in total

1.  Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

Authors:  A Takada; N Kuboki; K Okazaki; A Ninomiya; H Tanaka; H Ozaki; S Itamura; H Nishimura; M Enami; M Tashiro; K F Shortridge; H Kida
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Genetic characterization and mutation analysis of Qihe547 Aujeszky's disease virus in China.

Authors:  Cun Liu; Yanhan Liu; Ye Tian; Xuehua Wei; Yue Zhang; Fulin Tian
Journal:  BMC Vet Res       Date:  2018-07-06       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.